Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccine. (Q51986192)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 2005

Language	Label	Description	Also known as
English	Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccine.	scientific article published in December 2005

Statements

scholarly article

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccine. (English)

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

attenuated vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Cristiana Iosef

6

0 references

10

object named as

Linda J Saif

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

author name string

Trang V Nguyen

1

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Lijuan Yuan

2

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Marli S P Azevedo

3

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Kwang-Il Jeong

4

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Ana M Gonzalez

5

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Karin Lovgren-Bengtsson

7

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Bror Morein

8

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Peggy Lewis

9

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

language of work or name

0 references

publication date

1 December 2005

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

24

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

13

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

2302-2316

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

New vaccines to fight killer rotavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Tetravalent rhesus rotavirus vaccine in young infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Reappraisal of the Association of Intussusception with the Licensed Live Rotavirus Vaccine Challenges Initial Conclusions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Ecological studies, rotavirus vaccination, and intussusception.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Natural rotavirus infection is not associated to intussusception in Mexican children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Rotavirus vaccines: past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Epidemiological features of rotavirus infection in Caracas, Venezuela: implications for rotavirus immunization programs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Acquisition of Serum Antibody to Norwalk Virus and Rotavirus and Relation to Diarrhea in a Longitudinal Study of Young Children in Rural Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Human Rotavirus Type 2: Cultivation in Vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Comparative studies of the pathogenesis, antibody immune responses, and homologous protection to porcine and human rotaviruses in gnotobiotic piglets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Serum and intestinal isotype antibody responses to Wa human rotavirus in gnotobiotic pigs are modulated by maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Role of maternally derived circulating antibodies in protection of neonatal swine against porcine group A rotavirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Short-term immunoglobulin A B-cell memory resides in intestinal lymphoid tissues but not in bone marrow of gnotobiotic pigs inoculated with Wa human rotavirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Prevalence of antibodies to rotavirus in different age-groups of infants in Bochum, West Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Genetic analysis of the maternally induced affinity enhancement in the non-Ox1 idiotypic antibody repertoire of the primary immune response to 2-phenyloxazolone.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Protective levels of polysaccharide-specific maternal antibodies may enhance the immune response elicited by pneumococcal conjugates in neonatal and infant mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Adoptive transfer of natural antibodies to non-immunized chickens affects subsequent antigen-specific humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Modulation by colostrum-acquired maternal antibodies of systemic and mucosal antibody responses to rotavirus in calves experimentally challenged with bovine rotavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Maternal antibody blocks humoral but not T cell responses to BVDV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Priming for local and systemic antibody memory responses to bovine respiratory syncytial virus: effect of amount of virus, virus replication, route of administration and maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Regulation of VH gene repertoire and somatic mutation in germinal centre B cells by passively administered antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Pediatric viral gastroenteritis during eight years of study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.11.043

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51986192&oldid=1382090433"